Paper36768533
Biomarkers of Aggressive Prostate Cancer at Diagnosis.
Boehm BE and 4 others. Int J Mol Sci, 2023. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Biomarkers of Aggressive Prostate Cancer at Diagnosis. Papers, record 36768533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768533
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Male | |
| Humans | |
| United States | |
| Prostate | |
| Prostate-Specific Antigen | |
| Early Detection of Cancer | |
| Biopsy | |
| Biomarkers, Tumor |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25454615 | A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer. | Eur Urol | 2015 | https://conductscience.org/library/papers/25454615 | PubMed |
| 2 | 28111174 | A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer. | Clin Genitourin Cancer | 2017 | https://conductscience.org/library/papers/28111174 | PubMed |
| 3 | 32901135 | Cancer health disparities in racial/ethnic minorities in the United States. | Br J Cancer | 2021 | https://conductscience.org/library/papers/32901135 | PubMed |
| 4 | 35040965 | Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. | JAMA Netw Open | 2022 | https://conductscience.org/library/papers/35040965 | PubMed |
| 5 | 27108162 | Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score. | Eur Urol | 2016 | https://conductscience.org/library/papers/27108162 | PubMed |
| 6 | 22999998 | Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. | J Urol | 2013 | https://conductscience.org/library/papers/22999998 | PubMed |
| 7 | 29660369 | Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men. | Urology | 2019 | https://conductscience.org/library/papers/29660369 | PubMed |
| 8 | 32382078 | Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL. | Prostate Cancer Prostatic Dis | 2020 | https://conductscience.org/library/papers/32382078 | PubMed |
| 9 | 25636659 | Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men. | J Urol | 2015 | https://conductscience.org/library/papers/25636659 | PubMed |
| 10 | 18295257 | PCA3: a molecular urine assay for predicting prostate biopsy outcome. | J Urol | 2008 | https://conductscience.org/library/papers/18295257 | PubMed |
| 11 | 31629423 | African American and Asian males: what do we know about germline predisposition to prostate cancer. | Can J Urol | 2019 | https://conductscience.org/library/papers/31629423 | PubMed |
| 12 | 23201468 | Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. | Eur Urol | 2014 | https://conductscience.org/library/papers/23201468 | PubMed |
| 13 | 35292633 | Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes. | Nat Commun | 2022 | https://conductscience.org/library/papers/35292633 | PubMed |
| 14 | 23861782 | Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml. | PLoS One | 2013 | https://conductscience.org/library/papers/23861782 | PubMed |
| 15 | 26443432 | Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location. | Eur Urol | 2016 | https://conductscience.org/library/papers/26443432 | PubMed |
| 16 | 33792737 | MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33792737 | PubMed |
| 17 | 19297565 | Mortality results from a randomized prostate-cancer screening trial. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19297565 | PubMed |
| 18 | 27032035 | A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. | JAMA Oncol | 2016 | https://conductscience.org/library/papers/27032035 | PubMed |
| 19 | 33080150 | Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. | J Urol | 2021 | https://conductscience.org/library/papers/33080150 | PubMed |
| 20 | 34083737 | Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. | Commun Biol | 2021 | https://conductscience.org/library/papers/34083737 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958227 | Integration of bulk RNA-seq data with single-cell RNA-seq data to identify urinary biomarkers derived from prostate tumor tissues. | BMC Urol | 2026 | https://conductscience.org/library/papers/42958227 | PubMed |
| 42638975 | IL27 expression and IL27RA-dependent cellular responses are associated with biochemical recurrence and immune-regulatory features in prostate cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42638975 | PubMed |
| 42484820 | An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo-YAP/TAZ Axis. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42484820 | PubMed |
| 42195404 | Olfactory Science and Technology in Prostate Cancer Diagnosis: From Invertebrate Models to Artificial Intelligence. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42195404 | PubMed |
| 42153014 | Kombucha tea in cancer care: A review of its anti-cancer potential and role in integrative oncology. | Avicenna J Phytomed | 2026 | https://conductscience.org/library/papers/42153014 | PubMed |
| 42074564 | Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42074564 | PubMed |
| 42072359 | Integrative Whole-Genome and Epigenome Profiling of cfDNA in Familial Prostate Cancer: Insights from a Pilot Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/42072359 | PubMed |
| 41970982 | Development and validation of a clinical nomogram based on lasso-logistic regression for predicting prostate cancer with PSA 4-20.0 ng/mL: a retrospective study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41970982 | PubMed |
| 41762538 | From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41762538 | PubMed |
| 41607771 | Editorial: Streamlining drug approvals: addressing policy challenges in genitourinary oncology. | Front Immunol | 2025 | https://conductscience.org/library/papers/41607771 | PubMed |
| 41395283 | Diagnostic utility of serum prostate-specific antigen and circulating inflammatory markers for differentiating prostate cancer from benign prostatic hyperplasia. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/41395283 | PubMed |
| 41374944 | The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41374944 | PubMed |
| 41254603 | Prostate cancer misdiagnosed as prostatic abscess: case report and literature review. | BMC Urol | 2025 | https://conductscience.org/library/papers/41254603 | PubMed |
| 41050870 | Integrating Proteomic Analysis and Machine Learning to Predict Prostate Cancer Aggressiveness. | Stats (Basel) | 2024 | https://conductscience.org/library/papers/41050870 | PubMed |
| 40862934 | Shining the Path of Precision Diagnostic: Advancements in Photonic Sensors for Liquid Biopsy. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/40862934 | PubMed |
| 40861808 | A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer. | J Cancer | 2025 | https://conductscience.org/library/papers/40861808 | PubMed |
| 40849720 | METCAM/MUC18 is a Biomarker and Therapeutic Target for Prostate Cancer. | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/40849720 | PubMed |
| 40673839 | Roadblocks of Urinary EV Biomarkers: Moving Toward the Clinic. | J Extracell Vesicles | 2025 | https://conductscience.org/library/papers/40673839 | PubMed |
| 40606769 | Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions. | J Liq Biopsy | 2025 | https://conductscience.org/library/papers/40606769 | PubMed |
| 40445561 | Advance in prostate cancer biomarker discovery: bridging detection, prognosis and therapeutics. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40445561 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768533
GET https://conductscience.org/api/papers/v1/36768533/references?page=2